Stockreport

PTC Therapeutics Inc (PTCT) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... [Yahoo! Finance]

PTC Therapeutics, Inc.  (PTCT) 
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ptcbio.com
PDF Emflaza Net Product Revenue: $52 million. Evrysdi Royalty Revenue: $61 million. Non-GAAP R&D Expense: $152 million for Q3 2024. Non-GAAP SG&A Expense: $63 million [Read more]